» Articles » PMID: 29175500

Stress Hormones and Verbal Memory in Young People over the First 12 Weeks of Treatment for Psychosis

Abstract

Aims: Memory impairment in psychosis may be mediated through detrimental effects of hypothalamic-pituitary-adrenal (HPA) axis function. This study prospectively investigated the relationship between cortisol, sulphate dehydroepiandrosterone (DHEA(S) and cortisol: DHEA(S) ratio and memory in 35 first-episode psychosis (FEP) patients during the first 12 weeks of treatment and 23 healthy controls (HC).

Methods: Morning blood sampling and tests of attention, working memory and verbal memory occurred at baseline and 12-week follow-up.

Results: FEP and HC groups did not significantly differ in levels of cortisol, DHEA(S) or their ratio at baseline or over 12-weeks. The FEP group performed significantly below HC on all cognitive measures at baseline and over 12-weeks. Cortisol levels were unrelated to cognition in both groups. At baseline, DHEA(S) was positively associated with attention in HCs, but negatively associated with attention in FEP participants. Change in DHEA(S) was negatively associated with change in memory over 12-weeks in both groups. At 12-weeks, there was a negative correlation between the cortisol: DHEA(S) ratio and attention in both groups.

Conclusions: These findings are mostly in contrast to findings in chronic schizophrenia. Investigation at different illness phases and over longer-follow-up periods is required to determine the complex relationship between HPA-axis and memory functioning in psychosis.

Citing Articles

Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study.

Obdrzalkova M, Ustohal L, Hlavacova N, Mayerova M, ceskova E, Kasparek T Heliyon. 2023; 9(10):e21173.

PMID: 37916075 PMC: 10616415. DOI: 10.1016/j.heliyon.2023.e21173.


Cortisol and dehydroepiandrosterone sulfate in patients with schizophrenia spectrum disorders with respect to cognitive performance.

Misiak B, Piotrowski P, Chec M, Samochowiec J Compr Psychoneuroendocrinol. 2022; 6:100041.

PMID: 35757369 PMC: 9216421. DOI: 10.1016/j.cpnec.2021.100041.


Verbal memory measurement towards digital perspectives in first-episode psychosis: A review.

Kilciksiz C, Keefe R, Benoit J, Ongur D, Torous J Schizophr Res Cogn. 2020; 21:100177.

PMID: 32322540 PMC: 7163058. DOI: 10.1016/j.scog.2020.100177.


Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings.

Knytl P, Vorackova V, Dorazilova A, Rodriguez M, Cvrckova A, Kofronova E Front Psychiatry. 2019; 10:390.

PMID: 31275177 PMC: 6591670. DOI: 10.3389/fpsyt.2019.00390.


Pituitary Volume and Socio-Cognitive Functions in Individuals at Risk of Psychosis and Patients With Schizophrenia.

Takahashi T, Higuchi Y, Komori Y, Nishiyama S, Takayanagi Y, Sasabayashi D Front Psychiatry. 2018; 9:574.

PMID: 30473669 PMC: 6237858. DOI: 10.3389/fpsyt.2018.00574.